Business
Stock Market
Commodities
Finance
Tech
Sports
Nation
Trade & Policy

United States
Asia

Business

Corporates
SMEs
Startups
Funding
Marketing
Blog

Stock Market

Stock Market
Brokerages
Quarterly Results
Asian Markets
US Market

Finance

Stock Market
Personal Finance
Mutual Funds
IPO
Money Market
Cryptocurrency
Economy
Policy
Taxation

Tech

AI
Gadgets
Internet
Gaming
Science
Apps
Social Media
Cyber Security

Sports

Cricket
Soccer
Tennis
Hockey
Badminton
WWE
Kabaddi
NBA
Formula 1

Entertainment

Celebrity
Movies
Reviews
Box-Office
Television
OTT
Music
International

Sectors

Commodities
Fintech
Banking
Retail
Auto
Telecom
Defence
Energy
Real Estate
Health
Agriculture

Lifestyle

Beauty
Fashion
Books
Culture
Food
Fitness
Living
Parenting
Relationship
Travel
Wellness

More

India
USA
Asia
World

Home / Marksans Pharma

Marksans Pharma

Stay updated with the latest news and articles about Marksans Pharma.

Latest Articles

Marksans Pharma shares jump over 3% on Q2 results

Stock Market · Nov 12, 2024

By Aditya Bhagchandani

blank

Marksans Pharma Q2 FY25: Revenue up 20.84% YoY to Rs 641.92 crore, Net Profit up 16.56% YoY

Corporates · Nov 12, 2024

By Aditya Bhagchandani

blank

Marksans Pharma Q2 FY25 results: Stock surge over 3% ahead of result announcement

Stock Market · Nov 12, 2024

1
2

Showing 18 of 18 articles

Stock Market
Asian Markets
US Market
Brokerages
Quarterly Results

IPO
Money Market
Mutual Funds
Personal Finance
Cryptocurrency

Business
Corporates
Startups
SMEs
Funding
Blog

Download Mobile App

Get real-time market updates on the go

Add as a Preferred Source

Follow us for breaking news and exclusive updates

Daily Newsletter

Get the latest business news delivered to your inbox

About us·Partners·Ethics Policy ·Disclaimer·Terms & Conditions·Privacy Policy·Grievance Redressal·Refund Policy·Contact us

© 2026 Business Upturn. All rights reserved.

The information provided on this website is for general informational purposes only. Business Upturn does not provide investment, financial, or legal advice. Readers are advised to conduct their own research before making any financial decisions.

We use cookies to enhance your browsing experience and analyze our traffic. By continuing to use this site, you consent to our use of cookies. Privacy Policy